medroxyprogesterone acetate has been researched along with ulipristal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chaouat, M; Cimino, D; Communal, L; Courtin, A; de Bortoli, M; Faussat, AM; Forgez, P; Gompel, A; Mourra, N; Taverna, D; Vilasco, M | 1 |
| Choi, MR; Christov, K; Ivancic, D; Khan, SA; Lee, O | 1 |
| Altinoz, MA; Elmaci, I; Ozpinar, A | 1 |
1 review(s) available for medroxyprogesterone acetate and ulipristal
| Article | Year |
|---|---|
Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Topics: Animals; Antineoplastic Agents, Hormonal; Brain Neoplasms; Female; Glioma; Hormone Antagonists; Humans; Medroxyprogesterone Acetate; Meningioma; Mifepristone; Norpregnadienes; Progesterone; Progestins; Receptors, Progesterone | 2019 |
2 other study(ies) available for medroxyprogesterone acetate and ulipristal
| Article | Year |
|---|---|
Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells.
Topics: Adolescent; Adult; Breast; Breast Neoplasms; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Estradiol; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; High-Throughput Nucleotide Sequencing; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Norpregnadienes; Progesterone; Receptors, Estrogen; Receptors, Glucocorticoid; Receptors, Progesterone; RNA Interference; RNA, Small Interfering; Steroids; Transcriptome; Young Adult | 2012 |
Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Antigens, CD34; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Female; Hormone Antagonists; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Medroxyprogesterone Acetate; Methylnitrosourea; Mice; Mifepristone; Neovascularization, Pathologic; Norpregnadienes; Progesterone; Progestins; Rats; Receptors, Estrogen; Receptors, Progesterone; Time Factors | 2016 |